4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics Revenue

4D Molecular Therapeutics had revenue of $28.00K in the quarter ending March 31, 2024, a decrease of -90.60%. This brings the company's revenue in the last twelve months to $20.45M, up 826.31% year-over-year. In the year 2023, 4D Molecular Therapeutics had annual revenue of $20.72M with 562.29% growth.

• Revenue (ttm): $20.45M
• Revenue Growth: +826.31%
• P/S Ratio: 46.39
• Revenue / Employee: $139,129
• Employees: 147
• Market Cap: 948.76M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	20.72M	17.59M	562.29%
Dec 31, 2022	3.13M	-14.91M	-82.65%
Dec 31, 2021	18.04M	4.43M	32.52%
Dec 31, 2020	13.61M	6.63M	94.85%
Dec 31, 2019	6.99M	-7.14M	-50.56%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.